
Claude Science And Your R&D Diligence
Anthropic launched Claude Science, a research workbench that logs how every result was made. What it means for R&D-heavy businesses and the funds backing them.

Anthropic launched Claude Science, a research workbench that logs how every result was made. What it means for R&D-heavy businesses and the funds backing them.

Anthropic released Claude Sonnet 5 on June 30, 2026. What the new capability bar means for what you automate, your competitors, and your governance.

Mastercard's Agent Pay for Machines lets autonomous AI agents transact with each other directly. When no human approves each payment, your only control is a spending mandate you can verify.

One in five dealmakers walked away from an acquisition over AI. How AI exposure now decides whether a deal closes and at what price, for owners and buyers.

The EU chose the Domyn-led EUROPA consortium to build a sovereign, open European model above 400 billion parameters. Why a third AI option changes the dependency math.

German AI adoption reached 54.5% in 2026, but the Mittelstand sits at 47.2% against 67.2% for large firms. As the EU AI Act binds from August, that gap is no longer just competitive. It is a governance risk, and here is how to close it.

ChatGPT reportedly fell below 50% market share for the first time as Gemini and Claude rose. The AI-assistant market is fragmenting, and locking into one model is now a risk. Why a multi-model strategy wins.

Anthropic's run-rate revenue reportedly jumped from about 9 billion to 30 billion dollars, with 1,000+ companies each spending over a million a year. AI spend is now structural, and that changes how you should adopt.

Reports put Anthropic ahead of OpenAI in private market value for the first time. What the shift says about how investors now judge the lead in AI.

Nvidia says its checks to OpenAI and Anthropic are probably the last before they go public. Why the most invested believer trimming at the top is a signal worth reading.
Page 2 / 2